{"prediction": {"id": "258f68e1-80e6-5234-ba14-55c26c466ed0", "work_id": "3d7217c8-8f21-5030-95e3-4b0ada0e9404", "study_id": "554d4246-4274-50fb-bd4a-99323be9aefb", "kind": "Virtual population strategy comparison", "pages": [13], "version": "Version of record", "source_work_id": "3d7217c8-8f21-5030-95e3-4b0ada0e9404", "title": "[Does aspirin have a place in primary cardiovascular prevention by the polypill ? Simulation study on a realistic virtual population].", "doi": "10.1016/j.therap.2023.01.011", "pdf_sha256": "855ef4ec723b623c3a877dd47fbf5b1479615a6b00448e36c2103d414d45c425", "physical_page_count": 28}, "fields": {"endpoint": {"value": "cardiovascular_prevention_benefit_vs_bleeding_risk__fraction_above_benefit_risk_ratio_threshold", "source_basis": "verified_profile", "pages": [13]}, "family": {"value": "risk_estimate", "source_basis": "verified_profile", "pages": [13]}, "measured_variable": {"value": "cardiovascular_prevention_benefit_vs_bleeding_risk", "source_basis": "verified_profile", "pages": [13]}, "metric": {"value": "fraction_above_benefit_risk_ratio_threshold", "source_basis": "verified_profile", "pages": [13]}, "population": {"value": "human_observations", "source_basis": "verified_profile", "pages": [13, 15]}, "reference_type": {"value": "simulated_against_baseline", "source_basis": "verified_profile", "pages": [13]}, "role": {"value": "simulated_output", "source_basis": "verified_profile", "pages": [13]}, "scenario": {"value": "within_model_scenario_comparison", "source_basis": "verified_profile", "pages": [13]}}, "endpoints": [{"term": "risk_estimate", "label": "Risk and probability estimates"}, {"term": "treatment_effect", "label": "Treatment response and effect measures"}], "validations": [], "model_resources": {"total": 0, "page": 1, "limit": 50, "rows": [], "review_status": "indexed_source"}}